Value proposition
Transforming cancer and autoimmune treatments with unique IL-1RAP targeting approaches
Advesya is a pioneering and transformative biotechnology company developing therapies for difficult-to-treat cancers.
Haematology & Oncology, Antibody Drug Conjugate, Cell Therapy, and AutoimmuneOriginal language
Transforming cancer and autoimmune treatments with unique IL-1RAP targeting approaches
Advesya is a pioneering and transformative biotechnology company developing therapies for difficult-to-treat cancers.
Advesya - Transforming cancer and autoimmune treatments
Advesya is transforming the fight against cancer and autoimmune diseases. Building on years of academic research, advesya’s innovative work targets IL-1RAP.
https://advesya.com/
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
 | Le Réseau des Carnot | Other 11 Nov 2024 | | |
 | Institut Carnot CALYM | Other 6 Nov 2024 | | |
 DECA-BFC Startup accelerator & VC | DECA-BFC Startup accelerator & VC | Other 13 Mar 2024 | | |
 TEMIS Technopole Government Relations Services | TEMIS Technopole Government Relations Services | Other 7 Jun 2025 | | |
 Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Other 25 Jul 2024 | | |
 | Ministère de la Santé | Other 7 Feb 2024 | | |
 Ministère chargé de l'Enseignement supérieur et de la Recherche Government Administration | Ministère chargé de l'Enseignement supérieur et de la Recherche Government Administration | Other 7 Feb 2024 | | |
 Ministry of Economy Government Administration | Ministry of Economy Government Administration | Other 7 Feb 2024 | | |
 BFM Business Media, Broadcast Media Production and Distribution | BFM Business Media, Broadcast Media Production and Distribution | Other 5 Feb 2024 | | |
 Région Bourgogne-Franche-Comté National and local authorities, Government Administration | Région Bourgogne-Franche-Comté National and local authorities, Government Administration | Other 20 Dec 2023 | | |